| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/03/2008 | US20080160015 Monoclonal antibody for use in treatment of hemophila |
| 07/03/2008 | US20080160014 Immunoglobulin mixture for use in treatment of muscular dystrophy, cachexia and Type II diabetes |
| 07/03/2008 | US20080160013 Using immunoglobulin fusion comprising intergrin binding protein and src homology domains as therapeutic tool in treatment and prevention of cell proliferative and atherosclerotic disorders |
| 07/03/2008 | US20080160012 Using transmembrane protein with EGF-like and 2 follistatin-like domains 2 (TMEFF2) specific immunogllobulin for use in diagnosis, prevention and treatment prostate cancer |
| 07/03/2008 | US20080160011 Alpha-synuclein kinase |
| 07/03/2008 | US20080160010 Peptide That Elicits Neutralizing Antibodies Targeting the Hiv Co-Receptor |
| 07/03/2008 | US20080160009 Antibodies; calcium channel modulators (mibefradil); apoptosis resistance |
| 07/03/2008 | US20080159993 Immunotherapeutic methods using epitopes of WT-1 and GATA-1 |
| 07/03/2008 | US20080159989 Method of Promoting the Differentiation of Staminal Cells |
| 07/03/2008 | US20080159984 Compositions Capable of Facilitating Penetration Across a Biological Barrier |
| 07/03/2008 | US20080159983 Using antisense, ,immunmoglobulin and/or ribozymal agents to treat blood disorders |
| 07/03/2008 | US20080159981 Methods of therapy for cancers characterized by overexpression of the HER2 receptor protein |
| 07/03/2008 | US20080159980 Glutathione s-transferase (GST); kits |
| 07/03/2008 | US20080159979 Treatment of wounds using il-17b |
| 07/03/2008 | US20080159957 administrating a non-pathogenic, insect-specific virus to induce an immune response, and effective to cause cell death in the cell; cancer vaccines and immunotherapies; immunostimulants, biodrugs |
| 07/03/2008 | US20080159955 Inhibiting the growth of tumor cells overexpressing MN protein with enzyme inhibitors of carbonic anhydrase (CA 1X) (MN protein); pyridinium derivatives of aromatic heterocyclic sulfonamides; side-effect reduction; antitumor, -carcinogenic, -metastasis agents |
| 07/03/2008 | CA2832111A1 Antibodies and methods for making and using them |
| 07/03/2008 | CA2790018A1 Formulations |
| 07/03/2008 | CA2687208A1 Process and formulation for immunizing fish in aquaculture systems |
| 07/03/2008 | CA2676188A1 Pharmaceutical compositions capable of inducing apoptosis in tumour cells, useful for diagnosis and treatment of the b-chronic lymphocytic leukemia |
| 07/03/2008 | CA2676185A1 Pharmaceutical composition, comprising an anti-cd6 monoclonal antibody used in the diagnosis and treatment of rheumatoid arthritis |
| 07/03/2008 | CA2673725A1 Antibodies and methods for making and using them |
| 07/03/2008 | CA2673558A1 Multivalent pneumococcal polysaccharide-protein conjugate composition |
| 07/03/2008 | CA2673543A1 Multivalent pneumococcal polysaccharide-protein conjugate composition |
| 07/03/2008 | CA2673515A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 07/03/2008 | CA2673470A1 Methods for the treatment of lada and other adult-onset autoimmune diabetes using immunosuppressive monoclonal antibodies with reduced toxicity |
| 07/03/2008 | CA2673398A1 Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis |
| 07/03/2008 | CA2673376A1 Protein complex and uses |
| 07/03/2008 | CA2673373A1 Rsv f-protein and its use |
| 07/03/2008 | CA2673366A1 Novel prostate kallikrein allergen |
| 07/03/2008 | CA2673282A1 Antibodies to cd200r |
| 07/03/2008 | CA2672916A1 Cd44 antibodies |
| 07/03/2008 | CA2672715A1 Antibodies against insulin-like growth factor i receptor and uses thereof |
| 07/03/2008 | CA2671585A1 Treatment of diabetes by at least one epidermal growth factor receptor specific antibody or a derivative thereof |
| 07/02/2008 | EP1939295A1 Vaccine compostions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 07/02/2008 | EP1939294A1 Recombinant constructs of borrelia burgdorferi |
| 07/02/2008 | EP1939281A1 Immortalized Avian Cell Lines for Virus Production |
| 07/02/2008 | EP1939215A1 Omp85 proteins of neisseria gonorrhoeae and neisseria meningitidis, compositions containing same and methods of use thereof |
| 07/02/2008 | EP1938836A1 Compositions comprising a B subunit of shiga toxin and a means stimulating NKT cells |
| 07/02/2008 | EP1938835A1 Non-specific immunostimulating agents |
| 07/02/2008 | EP1938834A1 Treatment of type 1 diabetes before and after expression of predisposition markers |
| 07/02/2008 | EP1938833A1 Transfection of blood cells with mRNA for immune stimulation and gene therapy |
| 07/02/2008 | EP1938799A1 Methods and compositions for treating and preventing posterior segment ophthalmic disorders |
| 07/02/2008 | EP1938098A2 Universal rapid test and method for detection of tuberculosis in multiple host species |
| 07/02/2008 | EP1937827A1 Antibodies and their use in the treatment, prevention and diagnosis of a disease associated with sod1 abnormalities |
| 07/02/2008 | EP1937815A1 Methods and compositions for modulating tumor cell activity |
| 07/02/2008 | EP1937814A2 Anti-apoptotic protein antibodies |
| 07/02/2008 | EP1937721A2 Anit-il-23 antibiodies |
| 07/02/2008 | EP1937720A2 Single chain antibodies against beta-amyloid peptide |
| 07/02/2008 | EP1937712A2 Polynucleotides of haemophilus parasuis and its use |
| 07/02/2008 | EP1937313A2 Host cell lines for production of antibody constant region with enhanced effector function |
| 07/02/2008 | EP1937309A2 Regulatory cd8+t cells induced with anti-cd3 antibody |
| 07/02/2008 | EP1937308A1 Synthetic polyvalent carbohydrates as components of microbicides |
| 07/02/2008 | EP1937307A2 Specific removal of activated immune cells |
| 07/02/2008 | EP1937306A2 Proteolysis resistant antibody preparations |
| 07/02/2008 | EP1937305A1 Immunoglobulin comprising predominantly a man7glcnac2, man8glcnac2 glycoform |
| 07/02/2008 | EP1937304A2 Zwitterionization of capsular saccharides |
| 07/02/2008 | EP1937302A2 Methods and materials for producing a generic anti-amyloid immune response in mammals |
| 07/02/2008 | EP1937301A2 Functional influenza virus like particles (vlps) |
| 07/02/2008 | EP1937300A2 Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cells |
| 07/02/2008 | EP1937213A1 Systems and methods for manufacturing liposomes |
| 07/02/2008 | EP1459762B1 Use of emp9 for the prevention of proliferative organ diseases |
| 07/02/2008 | EP1171468B1 Method for the Stabilization of Chimeric Immunoglobulins or Immunoglobulin Fragments, and Stabilized Anti-EGP-2-scFv Fragment |
| 07/02/2008 | EP1169347B1 Compounds and methods for therapy and diagnosis of lung cancer |
| 07/02/2008 | EP1119349B1 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
| 07/02/2008 | EP0966300B1 Treatment of rheumatoid arthritis with antibody anti ifn gamma |
| 07/02/2008 | EP0896055B1 Apoptosis inducing protein and gene encoding the same |
| 07/02/2008 | EP0774002B1 Dna encoding ovine adenovirus (oav287) and its use as a viral vector |
| 07/02/2008 | CN101213213A Cardiovascular disease therapies |
| 07/02/2008 | CN101213212A Methods and compositions for impairing multiplication of HIV-1 |
| 07/02/2008 | CN101213211A Methods of purifying Fc region containing proteins |
| 07/02/2008 | CN101213210A Polypeptide, vaccine and use thereof |
| 07/02/2008 | CN101213207A Method for preparing a covalently cross linked oligomer of amyloid beta peptides |
| 07/02/2008 | CN101213204A 丙型肝炎病毒核酸疫苗 Hepatitis C virus DNA vaccine |
| 07/02/2008 | CN101212984A Process for attaching effector molecules to proteins |
| 07/02/2008 | CN101212983A A vaccine composition comprising alpha-galactosylceramide as an adjuvatnt for intranasal administration |
| 07/02/2008 | CN101210921A Rabbit anti-big gerbil immune serum |
| 07/02/2008 | CN101210248A ILTV gD glycoprotein nucleotide sequence and amino acid sequence, recombined virus bacterin thereof and application of the bacterin |
| 07/02/2008 | CN101210051A Anti-VEGF antibodies |
| 07/02/2008 | CN101210050A Anti-vegf antibodies |
| 07/02/2008 | CN101210049A Immunosuppressant-anti-CD25 mosaic monoclonal antibody |
| 07/02/2008 | CN101210048A Anti-CD33 engineering antibody for target conjugated marrow series leukemia cell and its expression vector and use |
| 07/02/2008 | CN101209351A Ankara vaccinia virus genetic engineering vaccine for pig replication and respiration complex |
| 07/02/2008 | CN100398653C Novel streptococcus antigens |
| 07/02/2008 | CN100398650C Recombinant human II type collagen functional polypeptide C II 250-270 and its preparation method and application |
| 07/02/2008 | CN100398551C Novel isoforms of vascular endothelial cell growth inhibitor |
| 07/02/2008 | CN100398156C Immunity regulating type DNA vaccine for preventing and treating chicken coccidiosis |
| 07/02/2008 | CN100398152C Novel human beta 2 integrin alpha subunit |
| 07/02/2008 | CN100398151C Ginsenoside nano microparticle and its preparing method and use |
| 07/02/2008 | CN100398150C Toxoplasma metabolic secretion antigen vaccine and its preparation process |
| 07/01/2008 | US7393949 Human immunodeficiency virus (HIV) nucleotide sequences |
| 07/01/2008 | US7393944 Lymphocytes; transcription factors; interferons |
| 07/01/2008 | US7393942 Nucleic acids encoding mutant forms of Fas ligand |
| 07/01/2008 | US7393941 screening assay to identify agents having antiviral activity against a DNA virus by assessing the effect of a candidate agent upon alternative splicing of MxA |
| 07/01/2008 | US7393933 Hepatitis B monoclonal antibodies |
| 07/01/2008 | US7393932 Endothelial cell expression patterns |
| 07/01/2008 | US7393928 Recombinant gelatins |
| 07/01/2008 | US7393927 Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof |
| 07/01/2008 | US7393851 Azaindole derivatives as inhibitors of p38 kinase |
| 07/01/2008 | US7393831 prophylactic and therapeutic vaccination directed against the hepatitis C virus |